[1]
Muren, O. et al. 2015. No effect of risedronate on femoral periprosthetic bone loss following total hip arthroplasty. Acta Orthopaedica. 86, 5 (Sep. 2015), 569–574. DOI:https://doi.org/10.3109/17453674.2015.1041846.